1. Introduction {#s0005}
===============

Calcified amorphous tumor (CAT) of the heart is a rare non-neoplastic intracavitary cardiac mass, with microscopic features of calcification and amorphous fibrinous material. Since its first description in 1997 as a specific entity by Reynolds and colleagues [@bb0005], several case reports have been published. Still, large series are lacking and, to date, we have no clear overview of the scope of the disease. In this article, we aim to perform a systematic review of the literature and to build a registry of all published cases of CAT in order to determine its clinical features, current management and prognosis.

2. Methods {#s0010}
==========

We performed a systematic search using PubMed, according to the preferred reporting items for systematic reviews and meta-analysis (PRISMA) guidelines, for articles reporting cases of CAT in the English language literature. Additional articles were identified by a manual search of references of relevant papers. Authors of articles were contacted, if needed, to obtain additional data that was of interest to our review. We included all articles published since the first report (May 1st, 1997) up to July 31st, 2014. The titles and abstract of the identified articles were screened to determine if they met inclusion criteria. Full text articles were then retrieved and reviewed. Reference lists of the retrieved articles were searched for relevant literature. Predetermined variables were first author, year of publication, title, journal, patient clinical informations (age, gender...), tumor size and location, presenting symptoms, associated conditions, treatment, follow-up and outcome.

3. Results {#s0015}
==========

A total of 27 articles reporting 42 cases of CAT were found. [Table A](#t0005){ref-type="table"} lists the clinical characteristics of the patients. [Table B](#t0010){ref-type="table"} reports the pooled clinical data. The mean age at presentation was 54 years (range 16--85), with a female predominance (64%). CAT was detected in all cardiac chambers, but predominated on the mitral valve or annulus (36%), in the right atrium (21%) or the right ventricle (17%). Mean tumor size was 29 × 17 mm, ranging from 1.7 mm punctate lesion to very large masses (20 × 90mm) or even diffuse left ventricular (LV) infiltration.Table AClinical characteristics of published cases of calcified amorphous tumor.ReportCase noSexAgeTumor sitePresentationFollow-upComorbidities/underlying diseaseSize (mm)TreatmentReynolds et al. (1997) [@bb0005]1M16LAExercise intolerance, near-syncopeResidual calcifications in LAMediastinal RT and chemo for neuroblastoma at age 3 months45 × 23 × 3Surgical excision2M30LVNear-syncope, chest pain, palpitationsSmall residual calcified nodule in LV, 3 years 6 monthsNone30 × 12 × 10Surgical excision3F33RVShortness of breathLost to follow-upRecurrent PE20 × 23Surgical excision4F34RVVertigo, orthopneaLost to follow-upSystemic lupus-like illness35 × 25 × 15Surgical excision5F48MVCVANED 4 monthsMR and TR, cleft mitral valve leaflet30 × 2Surgical excision6F60LV, MVCVA, retinal emboliAlive, left jugular foramen tumorMR and AR with enlarged LA15 × 15 × 15Surgical excision7M65RV, TVShortness of breathDied of non cardiac cause 30 days after diagnosisCAD, recurrent PE33 × 27 × 12No surgery8F67RASyncopeNED 18 yearsCAD, CHF65 × 50 × 50Surgical excision9M67LVSyncopeNED 1 year 4 monthsCAD, ESRD, tumoral calcinosis15 × 3 × 3Surgical excision10F73RA, SVCDizziness, dyspnea on exertionNED 1 year 5 monthsDiverticulitis, partial resection, total parenteral nutrition20 × 90Surgical excision11F75LV"Funny sensation" in chestNED 6 years 11 monthsDiabetes mellitus20 × 20 × 20Surgical excisionChaowalit et al. (2005) [@bb0075]12F20RVPE, dyspneaN/AChest trauma 3 years earlier40 × 22 × 18Surgical excisionLewin et al. (2006) [@bb0060]13F60RVSyncopeDied 1 day after surgeryNo prior cardiac history.40 × 30 × 25Surgical excisionFealey et al. (2007) [@bb0070]14F20RVPE, cough, shortness of breath, fatigueResidual calcified RV nodule, recurrent PE 2 years after surgical resection, second resectionNone40 × 35 × 25Surgical excisionKhulbey et al. (2008) [@bb0080]15M26RAProlonged fever and constitutional symptomsNED 1 yearAtrial septal closure30 × 20 × 20Surgical excisionInamdar et al. (2008) [@bb0085]16F85MAChronic fatigueN/AMAC, ESRD, HTN, DM23 × 9Surgical excisionHo et al. (2008) [@bb0015]17M44LV and mitral chordal apparatus diffuse infiltrationShortness of breath on exertionN/ASevere LV systolic dysfunctionDiffuse infiltrationReferred for heart transplantationGutierrez et al. (2008) [@bb0090]18M35RASeptic shockNED 2 monthsESRD (Alport syndrome), HTN20 × 15 × 14Surgical excisionFlynn et al. (2009) [@bb0095]19MYoungRVSyncope, PE, severe tricuspid regurgitationN/AN/A14 × 12 × 5Surgical excision and pulmonary TEAHabib et al. (2010) [@bb0025]20F58MA, MV, diffuse LV infiltrationVentricular tachycardiaMedical treatment, persistent VTVentricular tachycardia, SCD, mild mitral regurgitationDiffuse infiltrationMedical treatmentGupta et al. (2010) [@bb0100]21F40RAShortness of breath on exertion, cough, fatigueNED 8 monthsNone30 × 20 × 15Surgical excisionVaideeswar et al. (2010) [@bb0065]22M56RAProgressive shortness of breath, PE, blurring of visionNED 2 yearsN/AN/ASurgical excision and pulmonary TEA23M35RAExertional dyspnea, dizziness on walking, PEDied 7 days after surgeryN/A32 × 23 × 13Surgical excision and pulmonary TEAKubota et al. (2010) [@bb0040]24F64LV, MAIncidentalNED 3 yearsESRD, DM3 × 27Surgical excision25M44LV, PMIncidentalNED 3 yearsESRD6 × 28Surgical excisionGreaney et al. (2011) [@bb0105]26F69LV, MVLeft-sided heart failure, strokeNED 3 monthsSevere COPD20Surgical excisionAnanthakrishna et al. (2011) [@bb0110]27F45LVBreathlessnessNED 4 monthsRheumatic heart disease40 × 35 × 20Surgical excision, mitral and aortic valve replacementVlasseros et al. (2011) [@bb0010]28F65LV, MVVisual loss (central retinal artery occlusion)NED 8 monthsDM, HTN26 × 17 × 5Surgical excision and MVRLin et al. (2011) [@bb0115]29F74LAIncidentalNED 6 monthsNone14 × 27Surgical excisionDe Sousa et al. (2011) [@bb0120]30M17TVCardiomegalyNED 3 monthsEbstein anomaly15 × 15 × 13Surgical excision and TV valvuloplastyFujiwara et al. (2012) [@bb0035]31M58MAIncidentalN/AESRD, MACN/ASurgical excision32M65MAIncidentalN/AESRD, MAC7 × 2Surgical excisionNishigawa et al. (2012) [@bb0125]33F78LAIncidentalN/AMAC1.7Surgical excisionNazli et al. (2013) [@bb0020]34F54LVCentral retinal artery occlusionNED 1 yearHypothyroidism38 × 25Surgical excisionYamamoto et al. (2013) [@bb0130]35F82MAProgressive heart failureN/AN/A37 × 4Surgical excisionKawata et al. (2013) [@bb0045]36M59MAIncidentalN/ADM, ESRD, MAC28 × 6Surgical excisionRehman et al. (2014) [@bb0135]37F62RVSevere exertional dyspnea, chronic pulmonary embolismN/AAtrial septal defect30 × 20Surgical excisionMohamedali et al. (2014) [@bb0050]38F69MADyspnea, epigastric painN/AESRD, MAC7 × 3 × 3Surgical excisionChoi et al. (2014) [@bb0140]39F57RADyspnea, fever, coughNED 1 yearN/A19 × 13 × 8Surgical excisionHussain et al. (2014) [@bb0145]40F80LVNear-syncopeN/AHTN, dyslipidemia, CAD, lung adenocarcinoma50Surgical excision41F69MVPalpitationsN/AHTN, DM, dyslipidemia10 × 10Surgical excision and MV valvuloplasty42F60RADyspneaN/ABreast cancer 10 years earlier16 × 23Surgical excision[^1]Table BDemographic and clinical data of the population. (n = 42).VariablesValuesMale gender15 (36)Age, years54 ± 18CAT localization Mitral valve or annulus15 (36) Right atrium9 (21) Right ventricle7 (17) Left ventricle6 (14) Left atrium3 (7) Tricuspid valve or annulus2 (5)Tumor size, mm29 ± 16 × 17 ± 11Clinical presentation (multiple symptoms possible) Dyspnea19 (45) Syncope9 (21) Pulmonary embolism8 (19) Incidental7 (17) Systemic embolism5 (12) Chest pain2 (5) Other9 (21)Follow-up No evidence of disease, months12 \[2-216\] Residual disease3 (14) Recurrence1 (5) No data available (lost to follow-up or unavailable data)21 (50)Outcome Death (CAT or surgery related)2 (5)Associated conditions Valve disease13 (31) End stage renal disease9 (21) Mitral annulus calcification6 (14) Diabetes mellitus6 (14) Coronary artery disease5 (12) Hypertension4 (10) Congestive heart failure2 (5)Treatment Surgical excision39 (93) Other3 (7)[^2]

The most frequent presenting symptom was dyspnea (45%) followed by syncope (21%). Pulmonary or systemic embolization was reported in 31% of the cases. CAT was discovered incidentally in 17% of the patients.

The most frequently associated conditions were valve disease (31%) concomitant with MAC (14%), end-stage renal disease (ESRD) (21%), diabetes (14%), and coronary artery disease (12%).

Surgery was performed in most of the reported cases (93%), with a vast majority of favorable outcomes. Nonetheless, two patients died postoperatively (5%). Medical treatment was favored in 2 cases presenting diffuse calcium infiltration of the LV. Recurrence occurred in 1 case and residual calcifications were observed in 14% on follow-up imaging studies. The mean follow-up without evidence of disease was 12 months.

4. Discussion {#s0020}
=============

This review, encompassing all published cases of CAT allows giving a scope of this rare disease. However, there might have been some bias. Indeed, the condition is inherently underreported, since suspected but unoperated and thus unconfirmed cases were probably, were probably most of the time not reported.

Pathophysiologic hypotheses involving an organized thrombus origin favored by hypercoagulability [@bb0005] and/or phosphocalcic metabolism abnormalities [@bb0010] have been raised, but the pathogenesis of CAT remains poorly understood. Our review does not support the hypothesis of hypercoagulability.

Although endomyocardial biopsy was used for diagnosis in one case of diffuse LV infiltration [@bb0015], ruling out other cardiac masses or neoplasms requires surgery for histological confirmation in most of the cases, as clinical presentation of patients with cardiac masses tends to be similar. Current imaging cardiac techniques do not specifically differentiate cardiac CAT from other masses, but some features may contribute to establish the diagnosis [@bb0020]. On echocardiography, CAT usually appears as a calcified endocavitarian mass that may be located in any cardiac chamber, on any valves or on valvular annuli ([Fig. 1](#f0005){ref-type="fig"}). Size can vary from small punctate lesions to very large masses. Diffuse LV myocardial infiltrations have been reported [@bb0015], [@bb0025] but these forms probably constitute a distinct type of disease.Fig. 12D echocardiography of CAT (personal unpublished data).Echocardiographic four chamber view (Panel A) showing a mobile mass of 7 × 9 mm, attached on the ventricular side of the mitral annulus, close to the posterior commissure. Zoom view (Panel B) allows characterizing the relationship of the mass (small arrows) with the mitral leaflets (large arrows). LV, left ventricle; LA, left atrium.

Because of the calcifications, CAT can be mistaken for osteosarcoma, calcified myxoma or vegetations on imaging studies but the histopathologic appearance of the former is straightforward and entirely benign as it is composed of nodular calcium deposits surrounded by an amorphous hyalinized material [@bb0030] ([Fig. 2](#f0010){ref-type="fig"}). Clinical characteristics of the patient are also helpful, as patients frequently present concomitant conditions such as pre-existing valve disease (MAC for instance), end-stage renal disease (ESRD), or other cardiovascular risk factors. MAC-related CAT seems to constitute a subgroup of CAT, and is usually associated with ESRD [@bb0035], [@bb0040], [@bb0045], [@bb0050]. Kubota and colleagues proposed the descriptive term of "swinging calcified amorphous tumor" for mobile lesions arising from a MAC [@bb0040]. This subgroup of CAT seems to carry a high embolic risk, and rapid growth characteristics. Because of its mobile characteristics, one might postulate that CAT may causally contribute to the occurrence of stroke. However, the presence of MAC in itself is associated with an increased risk of stroke, independently of traditional risk factors [@bb0055]. In the current registry, CAT was associated with ESRD in 21% and with MAC in 14% of the patients.Fig. 2CAT microscopic image (personal unpublished data).Microscopic findings showing heterogeneous calcium deposits with surrounding amorphous eosinophilic and fibrinous material (hematoxilin and eosin, original × 100).

The discovery of CAT may be incidental, but most of the time symptoms are related to embolization or obstruction, depending on its size and location. The most common presenting symptoms in this registry were dyspnea, embolic event and syncope. An embolic event is a frequent presenting condition and mobile lesions definitely indicate a higher embolic risk [@bb0040]. However, traditional cardiovascular risk factors are highly prevalent, which may contribute to the high prevalence of cerebrovascular events at presentation. Less frequently, atypical chest pain or ventricular arrhythmia may occur but the etiological role of the CAT is unclear [@bb0025]. The growth rate of CAT is largely unknown, but may be relatively fast, especially in MAC-related CAT. Indeed, tumors growing very rapidly in a time span of 6 weeks to 1 year have been reported [@bb0040], [@bb0045].

Surgical resection remains the diagnostic and therapeutic standard for pedunculated lesions, although it carries some procedural risk: 2 patients (5%) died during the perioperative period [@bb0060], [@bb0065]. Recurrence after surgery seems infrequent as only 1 patient presented recurrent disease 2 years after surgical resection [@bb0070].

5. Conclusions {#s0025}
==============

Our systematic review, encompassing all published cases of CAT provides more insights into the clinical characteristics of this poorly known disease. Patients with CAT can present a large variety of symptoms, most of the time related to embolization or obstruction depending on the size and the location of the mass, but may also be discovered incidentally. CAT can arise from any cardiac chamber or valve, but in this review mitral valve and annulus appear to be its most frequent location and its size can vary from small punctate lesions to large pedunculated masses. Surgery is most of the time required to confirm diagnosis, and appears relatively safe. MAC-related CATs seem to constitute a subtype of this benign tumor, exhibiting specific characteristics including a rapid growth and a high embolic risk.

However, the natural history of the disease, its embolic potential as well as its best management strategy remain largely unknown. Therefore, there is a need for collecting the clinical data and building up a registry of all the patients presenting with echocardiographic features suggestive of CAT, in order better characterize the natural history of the disease, its outcome and the best therapeutic approach.
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[^1]: AR: aortic regurgitation, CAD: coronary artery disease, COPD: chronic obstructive pulmonary disease, CVA: cerebrovascular accident, DM: diabetes mellitus, ESRD: end-stage renal disease, F: female, HTN: hypertension, LA: left atrium, LV: left ventricle, M: male, MA: mitral annulus, MAC: mitral annular calcification, MR: mitral regurgitation, MV: mitral valve, N/A: not available, NED: no evidence of disease, PE: pulmonary embolism, PM: papillary muscle, RA: right atrium, RT: radiotherapy, RV: right ventricle, SCD: sudden cardiac death, TEA: thromboendarterectomy, TR: tricuspid regurgitation, TV: tricuspid valve, VT: ventricular tachycardia.

[^2]: Values are given as mean ± SD, no. (%), or median \[range\].
